First published online August 25, 2006
doi: 10.1242/10.1242/dev.02516
Development 133, 3709-3722 (2006)
Published by The Company of Biologists 2006
Hex acts with ß-catenin to regulate anteroposterior patterning via a Groucho-related co-repressor and Nodal
Andrea L. Zamparini1,*,
Tim Watts1,
Clare E. Gardner2,
Simon R. Tomlinson1,
Geoffrey I. Johnston2 and
Joshua M. Brickman1,
1 Centre Development in Stem Cell Biology, Institute for Stem Cell Research,
School of Biological Sciences, University of Edinburgh, King's Buildings, West
Mains Road, Edinburgh EH9 3JQ, UK.
2 Discovery Biology, Pfizer Global Research and Development, Ramsgate Road,
Sandwich CT13 9NJ, UK.

View larger version (58K):
[in a new window]
|
Fig. 1. Hex anteriorises the phenotypes induced by ß-catenin and
regulates its downstream targets. (A) Axis duplication phenotypes
induced by Hex and ß-catenin. Embryos were injected with 500 pg Hex,
ß-catenin, or both RNAs into a single-ventral blastomere at the four-cell
stage. In situ hybridisation was performed for the anterior neural marker
BF1 at stage 35. The inset and arrowheads indicate a small ventral
outgrowth produced by Hex injection. (B) Phenotypes induced by Hex and
ß-catenin in ventral marginal zone explants. Embryos were injected with
the indicated RNA into both blastomeres at the two-cell stage, cultured to
gastrulation, VMZ explants dissected and cultured until staging control
embryos reached stage 35. BF1 in situ hybridisation was performed to
highlight the phenotypes obtained. Hex RNA was injected at 500 pg.
(C,D) Real-time RT-PCR analysis of Siamois and
Xnr3 expression in VMZ explants analysed at stage 10.5. Embryos were
injected as in B with the indicated RNA. Values were normalised to the
expression level of Odc and the relative change in gene expression
for the genes analysed was calculated by dividing the values from injected
samples by the values from the uninjected. Data are based on three independent
experiments. (E) Cell automonous induction of ß-catenin targets
Siamois and Xnr3. RNA was injected into a single blastomere
at the four-cell stage with the indicated RNA alongside nucGFP RNA. Dorsal
injections are indicated with `D' where either 250 pg Hex or 100 pg
Hex- VP2 were used. Ventral injections are indicated with `V' where 500
pg Hex and 500 pg ß-catenin were used. Embryos were processed by double
in situ hybridisation and stained for both nucGFP to indicate the injected
cells (light blue) and Xnr3 (dark blue). The schematic diagram in the lower
right-hand corners of the lower panels indicates that the injection was
carried out in both blastomeres at the two-cell stage. The insets in
ß-catenin and ß-catenin co-injection with Hex show Xnr3 staining in
the animal hemisphere. Arrowheads indicate the site of injection. (F)
Expression of ß-catenin targets Siamois and Xnr3 in
embryos depleted of endogenous Hex. Embryos were injected with a total of 40
ng Hex MO or control MO at the two-cell stage, either alone or in combination
with 500 pg ß-catenin. 500 pg mouse Hex (mHex) was used to rescue the
phenotypes. Siamois (upper panel) and Xnr3 (lower panel)
expression was analysed by in situ hybridisation at stage 10.5. Arrowheads
indicate the ectopic expression induced by ß-catenin.
|
|

View larger version (46K):
[in a new window]
|
Fig. 2. Downstream response to the induction of early embryonic signalling by
Hex. (A) Real-time RT-PCR of Cerberus expression in VMZ
explants analysed at stage 10.5. Embryos were injected with the indicated RNA
and Cerberus expression quantified as in
Fig. 1C. Data are based on
three independent experiments. (B) In situ hybridisation for
Cerberus expression and double in situ for Cerberus (purple)
and nucGFP (light blue) expression at stage 10.5. Embryos were
injected with 500 pg Hex, ß-catenin or both at the two-cell stage into
both blastomeres (indicated with a schematic diagram in the lower right-hand
corner) or into a single-ventral blastomere at the four-cell stage (indicated
by `V') alongside a nucGFP RNA. Arrowheads indicate the site of injection.
(C,D) Real-time RT-PCR analysis of Goosecoid and
Chordin. Embryos were injected as in A and RNA from either animal
caps (C) or VMZ (D) explants extracted and analysed at stage 10.5. Values are
normalised to the expression level of Odc and the relative change in
gene expression for the genes analysed was calculated by dividing the values
from injected samples by the values from the uninjected. Data is based on
three independent experiments. (E) In situ hybridisation for
Goosecoid and Chordin expression at stage 10.5. Embryos were
injected with 500 pg Hex, ß-catenin, or both, at the four-cell stage into
a single-ventral blastomere alongside nucGFP. Double staining was performed.
Arrowheads indicate the injected cells. High-magnification views of embryos
co-injected with Hex and ß-catenin are shown for both Goosecoid
(indicated as Gsc) and Chordin (indicated as Chd)
expression. (F) Depletion of Hex by Hex MO. Embryos were injected as in
Fig. 1F and in situ
hybridisation for Cerberus, Goosecoid and Chordin performed
at stage 10.5. Arrowheads indicate the ectopic domain induced by
ß-catenin injection.
|
|

View larger version (58K):
[in a new window]
|
Fig. 6. Xtle4 overexpression antagonises Hex-amplification of Wnt
signalling. (A)In situ hybridisation for the expression of
Xnr3 and Cerberus at stage 10.5. Embryos were injected at
the two-cell stage in both blastomeres with 500 pg Hex, ß-catenin and/or
3000 pg Xtle4. (B) Activity of Hex and ß-catenin from the TOPflash
Wnt reporter gene in the presence of Xtle4. The indicated DNA was
co-transfected with either TOPflash or FOPflash in HEK 293T cells. Hex,
Hex- VP2 and ß-catenin were used at 100 ng, Xtle4 at 90 ng. Values
are represented as fold induction of the indicated reporters. Experiments were
carried out in triplicate.
|
|

View larger version (67K):
[in a new window]
|
Fig. 7. Hex suppresses the activity of Nodal-related TGFß
proteins. (A) Axis duplication phenotypes induced by Hex and
Xnr1. Embryos were injected into a single ventral-blastomere at the four-cell
stage with 500 pg Hex, 250 pg Xnr1 or both and in situ hybridisation carried
out at stage 35 using BF1. (B) Phenotypes induced by Hex and
Xnr1 in ventral marginal zone explants. Embryos were injected with the
indicated RNA at the two-cell stage, explants dissected at stage 10.5 and in
situ hybridisation for BF1 carried out when staging control embryos
reached stage 35. Hex was injected at 500 pg. Arrowheads indicate patches of
BF1 expression. (C) In situ hybridisation for the expression
of Cerberus at stage 10.5. Embryos were injected at the two-cell
stage in both blastomeres with 500 pg Hex and/or 250 pg Xnr1 mRNA. (D)
In situ hybridisation of Hex-depleted embryos for the mesendodermal markers
Cerberus, Goosecoid and Chordin. Embryos were injected as in
Fig. 1F. (E) Hex
suppresses the induction of mesoderm in animal cap explants. Embryos were
injected as in B with 500 pg Hex. Animal caps were dissected at blastula stage
and cultured in 8 U/ml Activin protein until control embryos reached stage 18.
(F) Molecular marker analysis in Hex-injected and Activin-treated
animal cap explants. Animal caps were isolated from embryos injected as in B,
cultured to stage 10.5 in 12 U/ml Activin, and RNA extracted for real-time
RT-PCR analysis for Goosecoid, Chordin, Xbra and Mixer.
Values are normalised to the expression level of Odc. Experiments
were carried out in triplicate.
|
|

View larger version (28K):
[in a new window]
|
Fig. 8. Schematic representation of Hex interactions with the Wnt and
Nodal-related pathways. At blastula stage, Hex amplifies Wnt signalling
through the repression of the Wnt antagonist Tle4. The Nieuwkoop centre genes
Siamois and Xnr3 are markers of this process and this
signalling centre is responsible for the induction of both anterior endoderm
and axial mesoderm. Following mesendoderm induction, Hex is expressed in the
anterior endoderm where it antagonises the propagation of the Nodal signal to
prevent mesoderm formation in the head field. Broken lines indicate the
induction of defined domains in the mesendoderm.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
© The Company of Biologists Ltd 2006